Amundi Asset Management US’s BioTelemetry, Inc. BEAT Stock Holding History

Amundi Asset Management US’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3,500	Closed	-$135K	–	1720
2020 Q1	$135K	Sell	3,500 -100	-3%	-$4.6K	﹤0.01%	1398
2019 Q4	$167K	Hold	3,600	–	–	﹤0.01%	1507
2019 Q3	$147K	Buy	+3,600	New	+$155K	﹤0.01%	1521
2019 Q2	–	Sell	-45,700	Closed	-$2.86M	–	1736
2019 Q1	$2.86M	Buy	45,700 +11,700	+34%	+$804K	﹤0.01%	1031
2018 Q4	$2.03K	Buy	34,000 +3,900	+13%	+$234K	﹤0.01%	1040
2018 Q3	$1.94M	Buy	+30,100	New	+$1.68M	﹤0.01%	1139

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amundi Asset Management US's BEAT Position: Q2 2020 in Review

Amundi Asset Management US sold out of BioTelemetry, Inc. (BEAT) in Q2 2020, closing a stake of 3,500 shares — an estimated $135K sold.

Amundi Asset Management US first reported a position in BEAT in Q3 2018 and held it in 6 quarters. The position peaked at $2.86M in Q1 2019. 215 funds tracked by Wall St. Rank hold BEAT as of Q2 2020.

Amundi Asset Management US reported no remaining BioTelemetry, Inc. position as of Q2 2020 after selling out during the quarter.
Amundi Asset Management US sold 3,500 BioTelemetry, Inc. shares in Q2 2020, an estimated $135K.
Amundi Asset Management US first reported a position in BioTelemetry, Inc. in Q3 2018 and held it in 6 quarters.
Amundi Asset Management US's BioTelemetry, Inc. position peaked at $2.86M in Q1 2019.
215 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2020.

Based on Amundi Asset Management US's 13F filing for Q2 2020, filed 14 Aug 2020.